help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, C.
Right arrow Articles by Billig, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ling, C.
Right arrow Articles by Billig, H.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 4 1804-1808
Copyright © 2003 by The Endocrine Society

Identification of Functional Prolactin (PRL) Receptor Gene Expression: PRL Inhibits Lipoprotein Lipase Activity in Human White Adipose Tissue

Charlotte Ling, Louise Svensson, Birgitta Odén, Birgitta Weijdegård, Barbro Edén, Staffan Edén and Håkan Billig

Department of Physiology (C.L., L.S., S.E., H.B.), The Wallenberg Laboratory (B.O.), and Department of Obstetrics and Gynecology (B.W., B.E.), Sahlgrenska University Hospital, Göteborg University, 405 30 Göteborg, Sweden

Address all correspondence and requests for reprints to: Dr. Håkan Billig, Department of Physiology, Göteborg University, P.O. Box 434, SE 405 30 Göteborg, Sweden. E-mail: hakan.billig{at}fysiologi.gu.se.

During lactation serum levels of prolactin (PRL) are elevated, and the activity of lipoprotein lipase (LPL) is decreased in the adipose tissue and increased in the mammary gland. However, PRL has been suggested to affect the adipose tissue in an indirect fashion during lactation. In the present study, we demonstrated expression of four PRL receptor (PRLR) mRNA isoforms (L, I, S1a, and S1b) in human sc abdominal adipose tissue and breast adipose tissue using RT-PCR/Southern blot analysis. In addition, L-PRLR [relative molecular mass (Mr) 90,000] and I-PRLR (Mr 50,000) protein expression was detected in human sc abdominal adipose tissue and breast adipose tissue using immunoblot analysis. Two additional protein bands with the molecular weight Mr 40–35,000 were also detected. The direct effect of PRL on the regulation of LPL activity in human abdominal adipose tissue cultured in vitro was investigated. PRL (500 ng/ml) reduced the LPL activity in human adipose tissue to 31 ± 7.7%, compared with control. GH (100 ng/ml) also reduced the LPL activity, to 45 ± 8.6%, compared with control. In agreement with previous studies, cortisol increased the LPL activity and GH inhibited cortisol-induced LPL activity. Furthermore, we found that PRL also inhibited the cortisol-induced LPL activity. Taken together, these results demonstrate a direct effect of PRL, via functional PRLRs, in reducing the LPL activity in human adipose tissue, and these results suggest that LPL might also be regulated in this fashion during lactation.

This work was supported by Grants 10380 and 13550 from the Swedish Medical Research Council and grants from The Royal Society of Arts and Sciences in Göteborg, The Swedish Society for Medical Research, and Assar Gabrielsson’s research fund.

C.L. and L.S. were equal contributors to this work.

Abbreviations: BMI, Body mass index; I, intermediate prolactin receptor isoform; L, long prolactin receptor isoform; Mr, relative molecular mass; LPL, lipoprotein lipase; PRL, prolactin; PRLR, PRL receptor; S1a and S1b, PRLR isoforms.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee
What Can We Learn from Rodents about Prolactin in Humans?
Endocr. Rev., February 1, 2008; 29(1): 1 - 41.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
U. A. White, A. A. Coulter, T. K. Miles, and J. M. Stephens
The STAT5A-Mediated Induction of Pyruvate Dehydrogenase Kinase 4 Expression by Prolactin or Growth Hormone in Adipocytes
Diabetes, June 1, 2007; 56(6): 1623 - 1629.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. L. Magnusson-Olsson, B. Hamark, A. Ericsson, M. Wennergren, T. Jansson, and T. L. Powell
Gestational and hormonal regulation of human placental lipoprotein lipase
J. Lipid Res., November 1, 2006; 47(11): 2551 - 2561.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
D. J Flint, N. Binart, S. Boumard, J. J Kopchick, and P. Kelly
Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity.
J. Endocrinol., October 1, 2006; 191(1): 101 - 111.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. R. LaPensee, N. D. Horseman, P. Tso, T. D. Brandebourg, E. R. Hugo, and N. Ben-Jonathan
The Prolactin-Deficient Mouse Has an Unaltered Metabolic Phenotype
Endocrinology, October 1, 2006; 147(10): 4638 - 4645.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. C. Hogan and J. M. Stephens
The Regulation of Fatty Acid Synthase by STAT5A
Diabetes, July 1, 2005; 54(7): 1968 - 1975.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society